Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathyRecruitingPhase 32026-05-28NCT07020819

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Annexon, Inc.3

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aarhus University HospitalAarhusDenmark5
Children'S Hospital of Orange CountyOrangeUnited States128
Henry Ford HealthDetroitUnited States75
HonorHealth Bob Bové Neuroscience InstituteScottsdaleUnited States1
Mayo Clinic FloridaJacksonvilleUnited States105
Mayo RochesterRochesterUnited States5
Ochsner LSU HealthShreveportUnited States1
Profound Research LLCCarlsbadUnited States3
St. Joseph's Hospital & Medical Center - Barrow Neurological InstitutePhoenixUnited States1
University Massachusetts Chan Medical SchoolWorcesterUnited States1
University of California IrvineOrangeUnited States49
University Of Colorado HospitalAuroraUnited States106
University of Kansas Medical CenterKansas CityUnited States240